YOLFTbeta
Osteopore Ltd

Osteopore Ltd

OSX · AU · Healthcare / Medical Instruments & Supplies

0.003AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.003
Open0.003
Day Range0.003 – 0.003
52-Week Range0.003 – 0.029
Volume9.33K
Market Cap2.77M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.03
50-Day Avg0.0043
200-Day Avg0.0066

About

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants and medical devices; and provides technology services, as well as engages in research and experimental development on biotechnology and medical science. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEODr. Yujing Lim Ph.D.
  • Employees0
  • Headquarters2 Tukang Innovation Grove #09-06/07, Singapore, Singapore, 618305, Australia
  • Websitehttps://www.osteopore.com

Leadership

  • Mr. Kei Wei LeongExecutive Chairman · b. 1976
  • Dr. Yujing Lim Ph.D.CEO, CTO & Executive Director
  • Ms. Shu Ning VoonGroup Financial Controller
  • Mr. Jack RosagroCompany Secretary

Financials

Income Statement

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue204.77K610.62K934.88K414.06K1.50M1.11M1.69M2.22M2.81M3.06M
Growth (%)-+198.20%+53.10%-55.71%+263.37%-26.03%+52.06%+31.02%+26.79%+8.74%
Cost of Revenue82.81K143.18K216.51K123.47K549.25K301.37K419.10K581.51K445.52K1.44M
Gross Profit121.96K467.44K718.37K290.59K955.33K811.64K1.27M1.64M2.37M1.62M
Gross Margin59.56%76.55%76.84%70.18%63.49%72.92%75.24%73.78%84.15%53.02%
Operating Expense1.18M996.32K1.62M2.66M3.60M4.71M5.50M6.56M5.19M4.29M
Operating Income-1.06M-528.88K-901.94K-2.37M-2.64M-3.89M-4.22M-4.93M-2.82M-2.67M
Operating Margin-517.74%-86.61%-96.48%-571.59%-175.76%-349.83%-249.50%-222.17%-100.28%-87.35%
EBITDA-924.43K-374.10K-793.16K-2.29M-1.76M-3.38M-3.97M-4.35M-2.34M-1.92M
EBITDA Margin-451.45%-61.27%-84.84%-554.06%-117.14%-303.60%-234.40%-196.13%-83.24%-62.86%
Net Income-972.77K-446.98K-870.25K-2.38M-1.95M-3.62M-4.22M-4.87M-3.35M-3.72M
Net Income Margin-475.06%-73.20%-93.09%-575.36%-129.33%-325.33%-249.09%-219.72%-119.24%-121.76%
R&D------1.43M1.57M1.14M1.45M
R&D as % of Total Revenue------84.21%70.84%40.44%47.58%
Interest Expense00015.63K17.60K16.30K20.38K15.05K426.02K279.96K
Interest Expense % of Total Revenue0.00%0.00%0.00%3.78%1.17%1.46%1.20%0.68%15.15%9.16%

Balance Sheet

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets858.80K349.61K5.40M4.28M10.25M6.01M3.62M3.34M3.13M2.77M
Total Liabilities2.22M2.18M1.17M1.32M1.25M633.40K1.51M2.91M2.83M4.50M
Total Equity-1.36M-1.84M4.23M2.97M9.00M5.37M2.11M432.60K306.22K-1.73M
Cash28.92K33.78K4.99M3.29M9.03M4.93M2.16M1.16M638.50K626.97K
Total Debt209.30K510.21K665.79K596.56K453.99K148.84K74.18K1.09M1.33M198.80K
Net Debt180.38K476.43K-4.32M-2.70M-8.57M-4.82M-2.09M-64.06K692.24K-428.17K

Cash Flow

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-184.27K11.16K-334.12K-1.75M-1.76M-3.81M-4.00M-3.74M-3.09M-2.56M
Investing Cash Flow-73.62K-49.19K1.47M407.27K-381.04K-194.62K-63.98K-7.37K-14.59K-10.79K
Financing Cash Flow263.17K35.63K-602.13K4.64M7.84M-485.88K896.32K3.58M2.63M2.67M
Capital Expenditure73.62K49.19K66.51K78.34K381.04K194.62K63.98K7.37K14.59K10.79K
Free Cash Flow-257.90K-38.03K-400.62K-1.83M-2.14M-4.00M-4.06M-3.74M-3.10M-2.57M
Dividends Paid------48.68K---
FCF to OCF139.95%-340.67%119.91%104.48%121.68%105.11%101.60%100.20%100.47%100.42%
Dividend Paid to FCF-------1.20%---

Earnings

Report DateSep 19, 2019Feb 28, 2020Aug 31, 2020Feb 26, 2021Aug 31, 2021Mar 31, 2022Aug 31, 2022Feb 28, 2023Apr 7, 2025Aug 29, 2025
EPS Estimate0.000.000.000.00-0.000.000.000.000.00
EPS Actual-0.01-0.05-0.01-0.01-0.01-0.02-0.02-0.02-0.04-0.01
Surprise----------
Timing-------After-hours--

Key Statistics & Ratios

Market Cap2.77M
Enterprise Value4.30M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.95
Price / Book15.36
EPS-0.01
Book Value-0.003
Revenue (TTM)2.93M
Gross Profit (TTM)2.36M
EBITDA-3.22M
Profit Margin-135.81%
Operating Margin-115.47%
Return on Equity-487.52%
Return on Assets-57.24%
Shares Outstanding693.59M
Shares Float558.13M
Beta0.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 22, 20241:15